Biggest News Aggregation in the World
📰 Yang Qinping News

Yang Qinping News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Yang Qinping. Real-time updates on events, politics, business and more.

Kintor Pharmaceutical : Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China -Today at 04:54 am

Suzhou, August 22, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company...
Kintor Pharma Yang Qinping Fudan University Huashan Hospital Kintor Pharmaceutical Limited Pharma Pharmaceutical Limited Professor Yang Qinping

Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...
Kintor Pharma Yang Qinping Kintor Pharmaceutical Limited Pharma Fudan University Huashan Hospital Kintor Pharmaceutical Kintor Pharmaceutical Limited

Kintor Pharmaceutical : Pharma Announces Completion of First Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

Suzhou, April 14, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has... | April 14, 2023
Yang Qinping Kintor Pharma Fudan University Kintor Pharmaceutical Limited Pharma Pharmaceutical Limited Huashan Hospital

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...
Kintor Pharma Zhang Jianzhong Yang Qinping Prnewswire Kintor Pharmaceutical Limited Pharma Kintor Pharmaceutical University People Hospital

Alopecia: New Clinical Trial Phase

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced the first dosing in its phase III clinical trial of KX-826 ("pyrilutamide") in China for the treatment of male androgenetic alopecia (AGA) patients on December 31, 2021. KX-826 is the first androgen receptor (AR) antagonist that has entered the phase III clinical trial for AGA treatment in China and globally. - Click here if this is yo...
Kintor Pharma Zhang Jianzhong Yang Qinping China National Medical Products Administration Fudan University University People Hospital

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Kintor Pharma Announces First Patient Dosing of Phase III Clinical Trial of KX-826 (Pyrilutamide) for Treating Androgenic Alopecia Patients in China

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...
Kintor Pharma Zhang Jianzhong Yang Qinping China National Medical Products Administration Fudan University Prnewswire Kintor Pharmaceutical Limited Pharma

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science